Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letters to the Editor
  • Published:

Reply to “Nonstop treatment of cystic fibrosis”

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Howard, M., Frizzell, R.A. & Bedwell, D.M. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nature Med. 2, 467–469 (1996).

    Article  CAS  PubMed  Google Scholar 

  2. Maquat, L.E. When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. RNA 1, 453–465 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Dietz, H.C. et al. The skipping of constitutive exons in vivo induced by nonsense mutations. Science 259, 680–683 (1993).

    Article  CAS  PubMed  Google Scholar 

  4. Dietz, H.C. & Kendzior, R.J., Jr. Maintenance of an open reading frame as an additional level of scrutiny during splice site selection. Nature Genet. 8, 183–188 (1994).

    Article  CAS  PubMed  Google Scholar 

  5. Hamosh, A. et al. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis. J. Clin. Invest. 88, 1880–1885 (1991).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hamosh, A., Rosenstein, B.J. & Cutting, G.R. CFTR nonsense mutations G542X and W1282X associated with severe reduction of CFTR mRNA in nasal epithelial cells. Hum. Mol. Genet. 1, 542–544 (1992).

    Article  CAS  PubMed  Google Scholar 

  7. Hull, J.S. et al. The stop mutation R553X in the CFTR gene results in exon skipping. Genomics 19, 362–364 (1994).

    Article  CAS  PubMed  Google Scholar 

  8. Dorin, J.R. et al. Phenotypic consequence of CFTR modulation in mutant mice: Implications for somatic gene therapy. Pediatr. Pulmonol. 12 (suppl.), 231 (1995).

    Google Scholar 

  9. Belgrader, P., Cheng, J. & Maquat, L.E. Evidence to implicate translation by ribosomes in the mechanism by which nonsense codons reduce the nuclear level of human triosephosphate isomerase mRNA. Proc. Natl. Acad. Sci. USA 90, 482–486 (1993).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Naeger, L.K., Schoberg, R.V., Zhao, Q., Tullis, G.E. & Pintel, D.J. Nonsense mutations inhibit splicing of MVM RNA in cis when they interrupt the reading frame of either exon of the final spliced product. Genes Dev. 6, 1107–1119 (1992).

    Article  CAS  PubMed  Google Scholar 

  11. Qian, L. et al. T cell receptor-β mRNA splicing: Regulation of unusual splicing intermediates. Mol. Cell. Biol. 13, 1686–1696 (1993).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Menon, K.P. & Neufeld, E.F. Evidence for degradation of mRNA encoding alpha-L-iduronidase in Hurler fibroblasts with premature termination alleles. Cell Mol. Biol. 40, 999–1005 (1994).

    CAS  PubMed  Google Scholar 

  13. Chang, J.C. & Kan, Y.W. β0 thalassemia, a nonsense mutation in man. Proc. Natl. Acad. Sci. USA 76, 2886–2889 (1979).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bedwell, D., Howard, M. & Frizzell, R. Reply to “Nonstop treatment of cystic fibrosis”. Nat Med 2, 608–609 (1996). https://doi.org/10.1038/nm0696-608c

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nm0696-608c

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing